The most pronounced differences, however, were seen in the expansion and activation of the intratumoral CD8+ lymphocytes (Fig. 3h), an effect that was further augmented by combination with systemic CTLA-4 blockade and was seen in the virus-injected tumours, distant tumours and spleen (Figs 5 and 6). The gene discussed is CTLA4; the disease is neoplasm.